Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Thoracic injection of low-dose interleukin-2 as an adjuvant therapy improves the control of the malignant pleural effusions: a systematic review and meta-analysis base on Chinese patients

Fig. 2

Efficacy comparison of cisplatin combined with IL-2 versus cisplatin alone by thoracic injection for controlling MPE. a Thoracic injection of cisplatin combined with IL-2 had a higher ORR compared with cisplatin alone (p < 0.001). b Thoracic injection of cisplatin combined with IL-2 had a higher DCR compared with cisplatin alone (p < 0.001); ORR, objective response rate; DCR, disease control rate; OR, odds ratio

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us